Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 11;7(12):1277.
doi: 10.1038/s41398-017-0042-1.

Huntingtin gene repeat size variations affect risk of lifetime depression

Affiliations
Review

Huntingtin gene repeat size variations affect risk of lifetime depression

Sarah L Gardiner et al. Transl Psychiatry. .

Abstract

Huntington disease (HD) is a severe neuropsychiatric disorder caused by a cytosine-adenine-guanine (CAG) repeat expansion in the HTT gene. Although HD is frequently complicated by depression, it is still unknown to what extent common HTT CAG repeat size variations in the normal range could affect depression risk in the general population. Using binary logistic regression, we assessed the association between HTT CAG repeat size and depression risk in two well-characterized Dutch cohorts─the Netherlands Study of Depression and Anxiety and the Netherlands Study of Depression in Older Persons─including 2165 depressed and 1058 non-depressed persons. In both cohorts, separately as well as combined, there was a significant non-linear association between the risk of lifetime depression and HTT CAG repeat size in which both relatively short and relatively large alleles were associated with an increased risk of depression (β = -0.292 and β = 0.006 for the linear and the quadratic term, respectively; both P < 0.01 after adjustment for the effects of sex, age, and education level). The odds of lifetime depression were lowest in persons with a HTT CAG repeat size of 21 (odds ratio: 0.71, 95% confidence interval: 0.52 to 0.98) compared to the average odds in the total cohort. In conclusion, lifetime depression risk was higher with both relatively short and relatively large HTT CAG repeat sizes in the normal range. Our study provides important proof-of-principle that repeat polymorphisms can act as hitherto unappreciated but complex genetic modifiers of depression.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing financial interests.

Figures

Fig. 1
Fig. 1. Distribution of HTT CAG repeat sizes
The figure displays the frequency distribution of the number of CAG repeats in the HTT gene in 2165 subjects with and 1058 subjects without a lifetime depression diagnosis, respectively
Fig. 2
Fig. 2. HTT CAG repeat size is non-linearly associated with lifetime depression risk
The red line indicates the model predicted mean odds ratio for lifetime depression for each HTT CAG repeat size (adjusted for age, sex, and education level): Both subjects with a relatively low and a relatively high repeat size have a higher odds of developing depression compared to the odds of depression in the total group. Error bars indicate ± standard error. Please note that there was only one subject (with depression) who had a HTT CAG repeat size of 14 in the longer allele, therefore, no standard error could be calculated for this CAG repeat category. Please also note that the logistic model estimates of odds ratios for lifetime depression are slightly different from those presented in Table 1 as these estimates are obtained using data from all participants simultaneously, whereas the estimates in Table 1 are calculated for each subgroup of HTT CAG repeat size separately
Fig. 3
Fig. 3. HTT CAG repeat size influences depression risk
The odds of a diagnosis of lifetime depression is non-linearly associated with CAG repeat size in the longer HTT allele: Both subjects with a relatively low and a relatively high repeat size have a higher risk of developing depression compared to the odds of depression in the total group. Error bars indicate ± standard error. *P < 0.05 by the Fisher’s exact test in comparison to the odds of lifetime depression in the total cohort

References

    1. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch. Gen. Psychiatr. 2005;62:1097–1106. doi: 10.1001/archpsyc.62.10.1097. - DOI - PubMed
    1. Marcus M., Yasamy M. T., Van Ommeren M., Chisholm D., Saxena S. Depression: A Global Public Health Concern, Vol. 1, 2 pp. (WHO Department of Mental Health and Substance Abuse, Geneva, Switzerland (2012).
    1. Ripke S, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatr. 2013;18:497–511. doi: 10.1038/mp.2012.21. - DOI - PMC - PubMed
    1. CONVERGE_consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature. 2015;523:588–591. doi: 10.1038/nature14659. - DOI - PMC - PubMed
    1. Okbay A, Baselmans BM, De Neve JE, Turley P, Nivard MG. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nature. 2016;48:624–633. - PMC - PubMed

Publication types